Thomas Decaens, Françoise Roudot‐Thoraval, Solange Bresson‐Hadni, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre‐Henri Bernard, Olivier Boillot, Karim Boudjema, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Dhumeaux, Daniel Cherqui, Christophe Duvoux – 22 June 2005 – The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known.

Tobias Schroeder, Massimo Malagó, Jörg F. Debatin, Mathias Goyen, Silvio Nadalin, Stefan G. Ruehm – 22 June 2005 – In order to compare the performance of “all‐in‐one” magnetic resonance imaging (MRI) and “all‐in‐one” multidetector computed tomography (MDCT) in the preharvest evaluation 25 potential living donors underwent both MRI and MDCT. MRI was performed on a high‐performance 1.5‐T scanner, computed tomography (CT) on a 4‐row multidetector‐scanner. Both scan protocols included angiography of the arterial and venous hepatic systems.

Michael Nalesnik – 22 June 2005

Georgia Kostopanagiotou, Kassiani Theodoraki, Ageliki Pandazi, Nikolaos Arkadopoulos, Konstantinos Kostopanagiotou, Vassilios Smyrniotis – 22 June 2005 – Liver transplantation has become a gold standard treatment for irreversible liver disease. Conventional measures of oxygenation are inadequate to understand the dynamics of regional oxygen metabolism during liver transplantation because they represent global markers of tissue dysoxia.

Matthew H. Nissing, Paul H. Hayashi – 22 June 2005 – There are no data regarding hepatic lobe donation effects on donor life insurability. Two investigators called 10 agents of 10 different large life insurance companies. One investigator gave a fictitious profile: Caucasian man, 33 years old, nonsmoker, without medical problems (control profile [CP]). The other investigator used the same profile with a history of uncomplicated right lobe donation 12 months earlier (donor profile [DP]). Investigators asked for premium quotes on a $100,000 term life policy.

22 June 2005

Mauricio Orrego, Linsheng Guo, Craig Reeder, Giovanni De Petris, Vijayan Balan, David D. Douglas, Thomas Byrne, Edwyn Harrison, David Mulligan, Hector Rodriguez‐Luna, Adyr Moss, Kunam Reddy, Jorge Rakela, Hugo E. Vargas – 22 June 2005 – B‐cell non‐Hodgkin's lymphoma (B‐NHL) is a well‐documented complication of hepatitis C virus (HCV) infection. Marginal zone (mucosa‐associated lymphoid tissue; MALT) lymphomas constitute a less common type of B‐NHL. In this article, we report a case of liver MALT in a cirrhotic patient, incidentally discovered after liver transplantation (LT).

Matthew R. Foxton, Lisa Knight, Alex S. Knisely, Ghulam J. Mufti, John O'Grady, Paolo Muiesan, Suzanne Norris – 22 June 2005 – End‐stage liver disease due to chronic hepatitis C virus (HCV) infection is now the most frequent indication for liver transplantation. HCV infection is associated with extrahepatic disease including cryoglobulinemia and lymphoma.

Pieter Evenepoel, Bert Bammens, Frederik Nevens, Alexander Wilmer, Yves Vanrenterghem – 22 June 2005

Elizabeth Anne Pomfret – 22 June 2005